Standard

Lymphoganuloma venereum in the Western world, 15 years after its re-emergence : new perspectives and research priorities. / de Vries, Henry J C.

In: Current opinion in infectious diseases, Vol. 32, No. 1, 02.2019, p. 43-50.

Research output: Contribution to journalReview articleAcademicpeer-review

Harvard

APA

Vancouver

de Vries HJC. Lymphoganuloma venereum in the Western world, 15 years after its re-emergence: new perspectives and research priorities. Current opinion in infectious diseases. 2019 Feb;32(1):43-50. doi: 10.1097/QCO.0000000000000519

Author

BibTeX

@article{5002295d5e304373aa4f94f6602f57bc,
title = "Lymphoganuloma venereum in the Western world, 15 years after its re-emergence: new perspectives and research priorities",
abstract = "PURPOSE OF REVIEW: Lymphogranuloma venereum (LGV) is a serious sexually transmitted infection caused by Chlamydia trachomatis. If left untreated LGV can cause irreversible late sequelae. LGV is endemic among a high-risk population of men who have sex with men (MSM), and largely reported in Western metropoles.RECENT FINDINGS: Although the majority of LGV patients are HIV positive, in recent years the proportion of HIV-negative MSM with LGV is rising. This could indicate a shift toward lower risk populations. Apart from a few European countries, no proper LGV surveillance efforts have been implemented so far. Moreover, a considerable proportion of the infections are asymptomatic. As a result, the true magnitude of the LGV epidemic is underestimated.Depending on the stage and location of infection, LGV manifests in a variety of clinical presentations. Among MSM, anorectal infections are overreported as opposed to genital LGV infections in a ratio of 15 to 1, respectively. Therefore, other modes of transmission apart from anal sex are here discussed.SUMMARY: To improve surveillance, cheaper and more practical screening methods are needed. Moreover, randomized clinical trials are needed to evaluate more simple treatment modalities as opposed to the currently recommended 3-week course of doxycycline.",
keywords = "Communicable Diseases, Emerging/epidemiology, Humans, Lymphogranuloma Venereum/epidemiology, Population Surveillance, Western World",
author = "{de Vries}, {Henry J C}",
year = "2019",
month = feb,
doi = "10.1097/QCO.0000000000000519",
language = "English",
volume = "32",
pages = "43--50",
journal = "Current opinion in infectious diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

RIS

TY - JOUR

T1 - Lymphoganuloma venereum in the Western world, 15 years after its re-emergence

T2 - new perspectives and research priorities

AU - de Vries, Henry J C

PY - 2019/2

Y1 - 2019/2

N2 - PURPOSE OF REVIEW: Lymphogranuloma venereum (LGV) is a serious sexually transmitted infection caused by Chlamydia trachomatis. If left untreated LGV can cause irreversible late sequelae. LGV is endemic among a high-risk population of men who have sex with men (MSM), and largely reported in Western metropoles.RECENT FINDINGS: Although the majority of LGV patients are HIV positive, in recent years the proportion of HIV-negative MSM with LGV is rising. This could indicate a shift toward lower risk populations. Apart from a few European countries, no proper LGV surveillance efforts have been implemented so far. Moreover, a considerable proportion of the infections are asymptomatic. As a result, the true magnitude of the LGV epidemic is underestimated.Depending on the stage and location of infection, LGV manifests in a variety of clinical presentations. Among MSM, anorectal infections are overreported as opposed to genital LGV infections in a ratio of 15 to 1, respectively. Therefore, other modes of transmission apart from anal sex are here discussed.SUMMARY: To improve surveillance, cheaper and more practical screening methods are needed. Moreover, randomized clinical trials are needed to evaluate more simple treatment modalities as opposed to the currently recommended 3-week course of doxycycline.

AB - PURPOSE OF REVIEW: Lymphogranuloma venereum (LGV) is a serious sexually transmitted infection caused by Chlamydia trachomatis. If left untreated LGV can cause irreversible late sequelae. LGV is endemic among a high-risk population of men who have sex with men (MSM), and largely reported in Western metropoles.RECENT FINDINGS: Although the majority of LGV patients are HIV positive, in recent years the proportion of HIV-negative MSM with LGV is rising. This could indicate a shift toward lower risk populations. Apart from a few European countries, no proper LGV surveillance efforts have been implemented so far. Moreover, a considerable proportion of the infections are asymptomatic. As a result, the true magnitude of the LGV epidemic is underestimated.Depending on the stage and location of infection, LGV manifests in a variety of clinical presentations. Among MSM, anorectal infections are overreported as opposed to genital LGV infections in a ratio of 15 to 1, respectively. Therefore, other modes of transmission apart from anal sex are here discussed.SUMMARY: To improve surveillance, cheaper and more practical screening methods are needed. Moreover, randomized clinical trials are needed to evaluate more simple treatment modalities as opposed to the currently recommended 3-week course of doxycycline.

KW - Communicable Diseases, Emerging/epidemiology

KW - Humans

KW - Lymphogranuloma Venereum/epidemiology

KW - Population Surveillance

KW - Western World

U2 - 10.1097/QCO.0000000000000519

DO - 10.1097/QCO.0000000000000519

M3 - Review article

C2 - 30507675

VL - 32

SP - 43

EP - 50

JO - Current opinion in infectious diseases

JF - Current opinion in infectious diseases

SN - 0951-7375

IS - 1

ER -

ID: 10855794